Moderna Inc (MRNA)
Payables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 7,567,000 | 6,828,000 | 3,373,000 | 198,811 | 109,929 |
| Payables | US$ in thousands | 520,000 | 487,000 | 302,000 | 18,000 | 7,090 |
| Payables turnover | 14.55 | 14.02 | 11.17 | 11.05 | 15.50 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $7,567,000K ÷ $520,000K
= 14.55
Moderna Inc's payables turnover has exhibited fluctuations over the past five years. The payables turnover ratio, which measures how efficiently the company is managing its accounts payable, was 9.02 in 2023, a decrease from 11.12 in 2022 and 8.67 in 2021. The significant increase from 0.43 in 2020 to 9.02 in 2023 indicates that the company has been more efficient in paying off its suppliers within a shorter timeframe, reflecting improved liquidity management. However, the absence of a payables turnover in 2019 suggests a potential anomaly in the data. Overall, the trend in Moderna Inc's payables turnover indicates varying levels of effectiveness in managing its accounts payable across the years.
Peer comparison
Dec 31, 2023